By Catherine Frompovich Thursday, March 3, 2011, just may be a high water mark in vaccine advocacy issues. Numerous vaccine safety advocates assembled on the apron of the massive front steps to the U.S. Supreme Court on First Street, NE, in Washington, DC, to let the court—and the world—know that the highest court in the […]
Novavax scores $97M federal vaccine deal
By Gazette Staff Novavax of Rockville scored a significant victory Monday when it won a federal contract worth up to $179 million to continue developing its new vaccines for seasonal and pandemic flu. The company this week also announced a licensing deal with a South Korean pharmaceutical company for producing and marketing flu vaccines there […]
Interview: Novavax's CEO discusses HHS flu vaccine funding
By Maureen Marino Earlier this week, the HHS doubled down on new vaccine technology. The government granted Maryland-based Novavax a contract worth up to $179.1 million, while Cranbury, NJ’s VaxInnate picked up a potential $196 million deal. Both companies are developing new approaches to seasonal and pandemic influenza that could help the country move away from slower, […]
Vaccination Profiteers Gang Up on Hannah Bruesewitz
By Evelyn Pringle The American Academy of Pediatrics announced the submission of an amicus brief to the US Supreme Court on July 30, 2010, “joined by 21 partnering health organizations,” in the vaccine injury case of Bruesewitz v Wyeth, to support the powerful vaccine maker against a lone family. Oral arguments in the case took […]
Government Backs Futuristic Flu Shots
By Matthew Herper The U.S. government is pledging $215 million — and as much as $375 million — to two biotechnology companies working to pioneer faster, more efficient ways to make vaccines for influenza. As was evident when the outbreak of the H1N1 swine flu swept across the country in 2009, our system for making […]
- « Previous Page
- 1
- …
- 21
- 22
- 23
- 24
- 25
- …
- 35
- Next Page »